Clinical Trials Directory

Trials / Completed

CompletedNCT02184104

Caffeine Disposition After Inhalation

Pharmacokinetics and Pharmacodynamics of a 100 mg Caffeine Dose After Oral Consumption of an Energy Drink or Inhalation Using the Aeroshot Administration Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Tennessee · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how fast caffeine gets into your body with a product called Aeroshot™. Aeroshot™ is a lipstick sized device that you slide open and then put your mouth over the opening and inhale. A fine powder containing 100 mg of caffeine is deposited on your tongue and the inside of your mouth. Caffeine will be absorbed through the membranes in your mouth or swallowed and then absorbed in your stomach. We will compare the absorption of caffeine after using the Aeroshot™ with the absorption after drinking an energy drink by taking 15 blood samples over 8 hours and measuring the caffeine levels in your blood. You will also be asked to fill out some scales to measure the effects you feel after the caffeine dose. We hypothesize that caffeine absorption after inhalation will be faster than after an energy drink.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeine

Timeline

Start date
2014-07-01
Primary completion
2015-11-01
Completion
2017-03-20
First posted
2014-07-09
Last updated
2017-10-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02184104. Inclusion in this directory is not an endorsement.